MTEX: Mannatech, Incorporated Stock

by  •  • Comments Off on MTEX: Mannatech, Incorporated Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 15.21
Enterprise Value ($M) 7.72
Book Value ($M) 10.48
Book Value / Share 5.56
Price / Book 1.45
NCAV ($M) -3.06
NCAV / Share -1.62
Price / NCAV -4.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.14
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.16

Liquidity (mrq)
Quick Ratio 0.49
Current Ratio 1.07

Balance Sheet (mrq) ($M)
Current Assets 27.66
Assets 41.21
Liabilities 30.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 131.96
Operating Income -0.93
Net Income -2.24
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.37
Cash from Investing -0.75
Cash from Financing -1.90

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 3 30 10.00
2024-04-30 2 141 1.42
2024-04-29 18 527 3.42

(click for more detail)

Similar Companies
MRNA – Moderna, Inc. MRSN – Mersana Therapeutics, Inc.
MRVI – Maravai LifeSciences Holdings, Inc. MYGN – Myriad Genetics, Inc.
NBIX – Neurocrine Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io